Home https://server7.kproxy.com/servlet/redirect.srv/sruj/smyrwpoii/p2/ Business https://server7.kproxy.com/servlet/redirect.srv/sruj/smyrwpoii/p2/ Dow rises as strong retail sales suggest consumer stays healthy by Investing.com

Dow rises as strong retail sales suggest consumer stays healthy by Investing.com



© Reuters.

By Yasin Ebrahim

Investing.com – Dow rallied on Friday as stronger retail sales suggesting the US consumer, the backbone of the economy, remains in good shape, helped ease investor concerns about a slowdown in the recovery.

The increase increased 0.91% or 259 points. It rose 0.60% while it rose 0.40%.

The Commerce Department said Friday that retail sales increased. It confused economists’ expectation of an increase of 0.5%. The retail control group ̵

1; which has a greater impact on US GDP – topped expectations for a 0.2% increase.

However, some economists warned that the data could represent the “last hurray” for the consumer towards the end of the year, as income is likely to fall due to a lack of stimulus.

“The strength in September may have been the last hurray for the consumer this year. With back to school / labor costs probably behind us and disposable income expected to contract sharply in Q3 4 without fresh fiscal stimulus, we will be lucky if consumption is flat in the 4th quarter, “Jefferies (NYSE 🙂 said in a note.

Despite small advances in stimulus negotiations, many believe it is about when rather than further federal aid is coming, with House President Nancy Pelosi hinting earlier this week that a finance package will be rolled out by January.

Utilities, industry and healthcare led the broader market higher, with the latter boosted by a rise in shares of Regeneron Pharmaceuticals (NASDAQ 🙂 and Pfizer .

Pfizer (NYSE 🙂 said it would apply for urgent US approval of its Covid-19 vaccine, which it is developing with Germany’s BioNTech in the third week of November. Pfizer rose more than 3% while Biontech Se (NASDAQ 🙂 added almost 4%.

The news helped restore some optimism over a Covid-19 vaccine after both Eli Lilly and Company (NYSE 🙂 and Johnson & Johnson (NYSE 🙂 announced setbacks earlier this week.

Technology, however, delayed the broader move higher, even though Fab 5 stocks traded mostly higher.

Amazon.com (NASDAQ :), Facebook (NASDAQ :), Google Mother Alphabet (NASDAQ 🙂 and Microsoft (NASDAQ 🙂 traded higher, while Apple (NASDAQ 🙂 fell 0.3%.

On the earnings front, investors digested mixed company reports.

The Bank of New York Mellon (NYSE 🙂 reported better-than-expected quarterly and bottom-line quarterly results, sending its stocks up 2%.

Schlumberger NV (NYSE 🙂 fell more than 7% after reported mixed results after its quarterly earnings slump, but revenue was less than estimates, pressured by coronavirus-led disruption in the drilling business.

In other news, Boeing (NYSE 🙂 rose 3% after the European Aviation Authority said the company’s malignant 737 Max jet was airworthy again.

Disclaimer: Fusion Media would like to remind you that the data on this site is not necessarily real-time or accurate. All CFDs (stocks, indices, futures) and Forex prices are not provided by stock exchanges, but rather by market makers, and therefore the prices may not be accurate and may deviate from the actual market price, which means that the prices are indicative and not suitable for commercial purposes. Fusion Media therefore bears no responsibility for any trading losses you may suffer as a result of the use of this data.

Fusion Media or anyone involved in Fusion Media assumes no responsibility for any loss or damage resulting from reliance on the information, including data, offers, charts and buy / sell signals contained on this site. Be fully informed about the risks and costs associated with trading the financial markets, it is one of the most risky forms of investment.




Source link